+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Needle Free Diabetes Care Market - Global Forecast 2026-2032- Product Image
Needle Free Diabetes Care Market - Global Forecast 2026-2032- Product Image
Sale

Needle Free Diabetes Care Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4968739
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Needle Free Diabetes Care Market is projected to reach USD 13.61 Billion in 2026. It is expected to continue growing at a CAGR of 6.39%, reaching USD 19.88 Billion by 2032.

Needle-free diabetes care is shifting diabetes management from episodic, painful interventions toward lower-friction monitoring, therapy, and digital self-management. The category includes noninvasive and minimally invasive glucose monitoring, continuous glucose monitoring, smart insulin delivery, jet injectors, inhaled insulin, transdermal concepts, and connected digital coaching designed to improve adherence and quality of life.

Demand is supported by the global diabetes burden. The International Diabetes Federation reported 537 million adults living with diabetes in 2021, with projections rising to 643 million by 2030. As payers, clinicians, and health systems prioritize adherence, prevention of complications, reduced hypoglycemia risk, and patient experience, needle-free and needle-sparing diabetes solutions are becoming a strategic healthcare priority.

Transformative Shifts in the Needle-Free Diabetes Care Landscape

The needle-free diabetes care landscape is being reshaped by three durable shifts: consumerization of chronic care, stronger reimbursement for connected monitoring, and movement from reactive glucose checks to continuous data-driven management. Regulatory-cleared continuous glucose monitoring has reduced dependence on routine fingersticks for many insulin-treated patients, while integrated insulin pumps and automated insulin delivery systems are reducing injection burden and improving time-in-range when used appropriately.

At the same time, fully noninvasive glucose monitoring remains scientifically demanding because accuracy must meet clinical safety standards across skin tones, hydration levels, temperature, motion, perfusion, medication use, and glucose variability. This creates opportunity for innovators that combine validated sensor science, human-centered design, interoperable platforms, and rigorous clinical evidence aligned with medical device regulatory expectations.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is compounding the value of needle-free diabetes care by turning high-frequency glucose, activity, food, sleep, medication, and insulin data into actionable decisions. AI-enabled algorithms can identify glycemic patterns, support hypoglycemia and hyperglycemia prediction, personalize alerts, optimize insulin delivery recommendations, and improve closed-loop system performance when validated under regulatory-grade evidence.

The strongest near-term impact is not replacing clinicians, but reducing therapeutic inertia and improving self-management between clinical visits. In regulated diabetes technology, AI adoption depends on explainability, cybersecurity, real-world performance monitoring, clinical risk controls, and bias testing, especially because diabetes outcomes are influenced by age, ethnicity, income, comorbidities, health literacy, and access to care.

Key Regional Insights

North America leads adoption due to a mature regulatory pathway for diabetes devices, strong diabetes screening, high use of continuous glucose monitoring, and expanding payer coverage, with the United States acting as the primary commercialization engine and Canada emphasizing equitable provincial access. Europe benefits from structured diabetes programs, health technology assessment pathways, and growing reimbursement for sensor-based monitoring, while European medical device regulation is increasing expectations for clinical evidence, post-market surveillance, and safety documentation.

Asia-Pacific is the largest long-term demand pool because China, India, Japan, South Korea, and Australia combine high diabetes prevalence, aging populations, rapid digital health adoption, and expanding specialist care capacity. Latin America is advancing through private-sector uptake and public health modernization in Brazil and Mexico, although affordability and uneven reimbursement remain constraints. The Middle East, led by Gulf countries with high diabetes prevalence, is investing in preventive care, smart hospitals, and digital health infrastructure. Africa remains underpenetrated, but mobile health, primary care expansion, donor-supported chronic disease programs, and lower-cost monitoring models are creating a foundation for broader access to needle-free and needle-sparing diabetes care.

Key Group Insights

ASEAN markets are attractive because young populations, rising urbanization, expanding private healthcare, and growing metabolic disease awareness are increasing diabetes diagnosis and demand for convenient monitoring. The GCC is a high-priority group because diabetes prevalence is elevated and governments are funding digital health infrastructure, preventive care, screening programs, and specialty diabetes centers that can support connected glucose monitoring and needle-sparing therapies.

The European Union provides scale through harmonized medical device regulation and coordinated health policy, although evidence generation under MDR has raised compliance and post-market monitoring expectations. BRICS economies represent substantial access-driven opportunity because China, India, Brazil, Russia, and South Africa combine population scale with uneven diagnosis, reimbursement, and specialist availability. G7 countries anchor premium adoption, reimbursement innovation, clinical validation, and digital health governance, while NATO-aligned markets benefit indirectly from advanced health infrastructure, data protection practices, and cybersecurity standards that are increasingly relevant for connected diabetes devices.

Key Country Insights

The United States is a leading innovation and reimbursement market, supported by CDC-documented diabetes prevalence, strong endocrinology networks, and broad use of continuous glucose monitoring among insulin-treated patients. Canada emphasizes provincial coverage, clinical guidelines, and equitable access, while Mexico and Brazil show rising demand tied to obesity, urban lifestyles, growing private healthcare use, and public health efforts to address diabetes complications. In Europe, the United Kingdom, Germany, France, Italy, and Spain support evidence-based adoption through guideline-driven care, reimbursement assessment, and structured diabetes services, while Russia remains a sizable but more access-sensitive market influenced by affordability, distribution, and healthcare infrastructure.

China and India are the most important long-term volume markets due to the scale of diabetes prevalence identified by IDF data and the need for scalable, lower-friction monitoring models. Japan favors high-quality connected care for an aging population, South Korea combines advanced digital infrastructure with strong technology adoption, and Australia supports validated diabetes technologies through specialist care, national health programs, and remote monitoring relevance for geographically dispersed populations. Across these countries, adoption depends on proven accuracy, usability, reimbursement fit, local clinical evidence, and integration with broader diabetes care pathways.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated accuracy, patient comfort, and reimbursement evidence over novelty. Products that reduce pain but fail to demonstrate safety, outcomes, workflow efficiency, and real-world usability will face slow adoption. Developers should design for affordability, interoperability with electronic health records, integration with insulin delivery, pharmacy services, remote patient monitoring, and support for diabetes education.

Strategically, leaders should invest in diverse clinical trials, post-market evidence, cybersecurity, human factors testing, and AI governance. Partnerships with endocrinologists, primary care networks, payers, pharmacies, diabetes educators, and digital health programs can accelerate adoption. Emerging markets require tiered pricing, local distribution, multilingual training, robust service models, and care pathways that reduce total cost of diabetes management rather than adding isolated device expense.

Research Methodology

This executive summary is based on secondary research from recognized public health, regulatory, and clinical sources, including the International Diabetes Federation, World Health Organization, U.S. Centers for Disease Control and Prevention, medical device regulatory guidance, peer-reviewed diabetes technology literature, clinical practice guidelines, and regional healthcare policy evidence.

The analysis evaluates disease burden, adoption readiness, reimbursement trends, regulatory requirements, technology maturity, patient usability, interoperability, and competitive positioning. Insights were synthesized to identify practical growth drivers for needle-free and needle-sparing diabetes care while avoiding unsupported market-size claims, market share references, forecasts, or unverified commercial assumptions.

Conclusion

Needle-free diabetes care is moving from a convenience concept to a strategic pillar of chronic disease management. The strongest opportunities sit at the intersection of accurate sensing, connected therapeutics, AI-enabled decision support, patient-centered design, and reimbursement models that reward adherence, early intervention, and prevention of complications.

Although fully noninvasive glucose monitoring still faces clinical validation hurdles, the broader needle-free and needle-sparing ecosystem is advancing through continuous glucose monitoring, automated insulin delivery, inhaled insulin, jet injection, and connected care platforms. Organizations that prove safety, outcomes, usability, cybersecurity, and economic value across diverse populations will be best positioned to support long-term progress in global diabetes care.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Needle Free Diabetes Care Market, by Product Type
7.1. Introduction
7.2. GLP-1 Delivery Systems
7.3. Insulin Delivery Systems
7.3.1. Prefilled Devices
7.3.2. Refillable Devices
8. Needle Free Diabetes Care Market, by Age Group
8.1. Introduction
8.2. Adult
8.3. Geriatric
8.4. Pediatric
9. Needle Free Diabetes Care Market, by Technology
9.1. Introduction
9.2. Jet Injectors
9.3. Microneedles
9.3.1. Coated
9.3.2. Dissolvable
9.3.3. Hollow
9.3.4. Solid
9.4. Patch Pumps
10. Needle Free Diabetes Care Market, by Application
10.1. Introduction
10.2. Gestational Diabetes
10.3. Type 1 Diabetes
10.4. Type 2 Diabetes
11. Needle Free Diabetes Care Market, by End User
11.1. Introduction
11.2. Ambulatory Care Centers
11.3. Home Care
11.4. Hospitals & Clinics
11.5. Specialty Clinics
12. Needle Free Diabetes Care Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacy
12.3. Online Pharmacy
12.4. Retail Pharmacy
13. Needle Free Diabetes Care Market, by Region
13.1. Asia-Pacific
13.2. North America
13.3. Latin America
13.4. Europe
13.5. Middle East
13.6. Africa
14. Needle Free Diabetes Care Market, by Group
14.1. ASEAN
14.2. GCC
14.3. European Union
14.4. BRICS
14.5. G7
14.6. NATO
15. Needle Free Diabetes Care Market, by Country
15.1. United States
15.2. Canada
15.3. Mexico
15.4. Brazil
15.5. United Kingdom
15.6. Germany
15.7. France
15.8. Russia
15.9. Italy
15.10. Spain
15.11. China
15.12. India
15.13. Japan
15.14. Australia
15.15. South Korea
16. Competitive Landscape
16.1. Market Share Analysis, 2025
16.2. FPNV Positioning Matrix, 2025
16.3. Market Concentration Analysis, 2025
16.3.1. Concentration Ratio (CR)
16.3.2. Herfindahl Hirschman Index (HHI)
16.4. Recent Developments & Impact Analysis, 2025
16.5. Product Portfolio Analysis, 2025
16.6. Benchmarking Analysis, 2025
17. Company Profiles
17.1. Abbott Laboratories
17.2. Becton, Dickinson and Company
17.3. CeQur SA
17.4. Crossject SA
17.5. Eli Lilly and Company
17.6. Gerresheimer AG
17.7. Insulet Corporation
17.8. Jiangsu Delfu medical device Co., Ltd.
17.9. NuGen Medical Devices Inc.
17.10. PharmaJet, Inc.
17.11. Portal Instruments, Inc.
17.12. Sanofi S.A.
17.13. Terumo Corporation
17.14. Valeritas Holdings, Inc.
17.15. West Pharmaceutical Services, Inc.
List of Figures
FIGURE 1. GLOBAL NEEDLE FREE DIABETES CARE MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL NEEDLE FREE DIABETES CARE MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL NEEDLE FREE DIABETES CARE MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2025 VS 2032 (%)
FIGURE 9. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 11. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 13. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 15. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 17. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 19. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 21. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 22. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 23. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 24. GLOBAL NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 25. GLOBAL NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL NEEDLE FREE DIABETES CARE MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL GLP-1 DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL GLP-1 DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL GLP-1 DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL INSULIN DELIVERY SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL INSULIN DELIVERY SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL INSULIN DELIVERY SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL PREFILLED DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL PREFILLED DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL PREFILLED DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REFILLABLE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REFILLABLE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REFILLABLE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL ADULT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL ADULT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL ADULT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL GERIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL GERIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL GERIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL PEDIATRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL PEDIATRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL PEDIATRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL JET INJECTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL JET INJECTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL JET INJECTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL MICRONEEDLES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL MICRONEEDLES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL MICRONEEDLES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL COATED MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL COATED MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL COATED MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL DISSOLVABLE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL DISSOLVABLE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL DISSOLVABLE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL HOLLOW MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL HOLLOW MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL HOLLOW MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL SOLID MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL SOLID MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL SOLID MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL PATCH PUMPS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL PATCH PUMPS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL PATCH PUMPS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL GESTATIONAL DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TYPE 1 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL TYPE 2 DIABETES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL HOME CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL HOME CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL HOME CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL HOSPITAL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL ONLINE PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL ONLINE PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL ONLINE PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL RETAIL PHARMACY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL RETAIL PHARMACY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL RETAIL PHARMACY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 83. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 84. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 85. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 86. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 87. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 88. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 89. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 90. ASIA-PACIFIC NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 91. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 92. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 93. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 94. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 95. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 96. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 97. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 98. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 99. NORTH AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 100. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 102. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 103. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 104. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 105. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 106. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 107. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 108. LATIN AMERICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 109. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 111. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 112. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 113. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 114. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 115. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 116. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 117. EUROPE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 118. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 119. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 120. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 121. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 122. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 123. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 124. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 125. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 126. MIDDLE EAST NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 127. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 128. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 129. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 130. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 131. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 132. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 133. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 134. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 135. AFRICA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 137. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 139. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 140. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 141. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 142. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 143. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 144. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 145. ASEAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 146. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 148. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 149. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 150. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 151. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 152. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 153. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 154. GCC NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 155. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 157. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 158. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 159. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 160. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 161. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 162. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 163. EUROPEAN UNION NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 164. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 166. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 167. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 168. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 169. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 170. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 171. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 172. BRICS NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 173. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 174. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 175. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 176. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 177. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 178. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 179. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 180. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 181. G7 NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 182. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 183. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 184. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 185. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 186. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 187. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 188. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 189. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 190. NATO NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 191. GLOBAL NEEDLE FREE DIABETES CARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 192. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 193. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 195. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 196. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 197. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 198. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 199. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 200. UNITED STATES NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 201. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 202. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 203. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 204. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 205. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 206. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 207. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 208. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 209. CANADA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 210. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 211. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 212. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 213. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 214. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 215. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 216. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 217. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. MEXICO NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 219. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 220. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 221. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 222. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 223. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 224. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 225. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 227. BRAZIL NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 228. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 229. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 230. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 231. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 232. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 233. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 234. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 235. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 236. UNITED KINGDOM NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 237. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 238. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 239. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 240. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 241. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 243. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 244. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 245. GERMANY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 246. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 247. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 248. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 249. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 250. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 251. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 252. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 253. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. FRANCE NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 255. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 256. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 258. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 259. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 260. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 261. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 262. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 263. RUSSIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 264. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 265. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 266. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 267. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 268. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 269. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 270. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 271. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 272. ITALY NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 273. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 274. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 275. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 276. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 277. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 278. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 279. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 280. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 281. SPAIN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 282. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 283. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 284. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 285. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 286. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 287. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 288. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 289. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 290. CHINA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 291. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 292. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 293. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 294. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 295. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 296. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 297. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 298. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 299. INDIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 300. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 301. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 302. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 303. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 304. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 305. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 306. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 307. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 308. JAPAN NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 309. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 310. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 311. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 312. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 313. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 314. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 315. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 316. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 317. AUSTRALIA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 318. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 319. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 320. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY INSULIN DELIVERY SYSTEMS, 2017-2032 (USD MILLION)
TABLE 321. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY AGE GROUP, 2017-2032 (USD MILLION)
TABLE 322. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 323. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY MICRONEEDLES, 2017-2032 (USD MILLION)
TABLE 324. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 325. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 326. SOUTH KOREA NEEDLE FREE DIABETES CARE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 327. GLOBAL NEEDLE FREE DIABETES CARE MARKET SHARE, BY KEY PLAYER, 2025
TABLE 328. GLOBAL NEEDLE FREE DIABETES CARE MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • CeQur SA
  • Crossject SA
  • Eli Lilly and Company
  • Gerresheimer AG
  • Insulet Corporation
  • Jiangsu Delfu medical device Co., Ltd.
  • NuGen Medical Devices Inc.
  • PharmaJet, Inc.
  • Portal Instruments, Inc.
  • Sanofi S.A.
  • Terumo Corporation
  • Valeritas Holdings, Inc.
  • West Pharmaceutical Services, Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 13.61 Billion
Forecasted Market Value ( USD ) by 2032 $ 19.88 Billion
Compound Annual Growth Rate6.3%
Regions CoveredGlobal
No. of Companies Mentioned15

Related Topics

Related Reports

Needle Free Injection System Market - Global Forecast 2026-2032 - Product Image

Needle Free Injection System Market - Global Forecast 2026-2032

  • Report
  • 193 Pages
  • Global
From
Disposable Sterile Insulin Syringe Market - Global Forecast 2026-2032 - Product Image

Disposable Sterile Insulin Syringe Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Needle Free Diabetes Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

Needle Free Diabetes Care Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 192 Pages
  • Global
From
Needle Free Diabetes Care Market - Global Strategic Business Report - Product Image

Needle Free Diabetes Care Market - Global Strategic Business Report

  • Report
  • 284 Pages
  • Global
From
Needles - Global Strategic Business Report - Product Image

Needles - Global Strategic Business Report

  • Report
  • 425 Pages
  • Global
From

About the Needle Free Diabetes Market

The Needle Free Diabetes market is a subset of the Medical Devices industry, focusing on the development of products that allow diabetics to monitor and manage their condition without the need for needles. These products are designed to provide a more convenient and comfortable experience for patients, while also reducing the risk of infection. Needle Free Diabetes products include continuous glucose monitoring systems, insulin pumps, and other devices that allow for the delivery of insulin without the use of needles. The Needle Free Diabetes market is driven by the increasing prevalence of diabetes, as well as the need for more convenient and comfortable treatments. Additionally, the development of new technologies and the increasing availability of these products are expected to drive further growth in the market. Some of the major companies in the Needle Free Diabetes market include Medtronic, Insulet Corporation, Tandem Diabetes Care, and Dexcom. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.